{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T04:47:19.235235+00:00","published_at":"2026-10-17T04:47:19.235235+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:jb0v3z16x96zj","event_type":"CFO_CHANGED","effective_at":"2025-10-24","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:person:christopher-s-downs","alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:1fe3b304eba1ddddf47b03ae23aa7ab289c39ec2888c011ef4c75a6ceb621ff7"],"summary":"Christopher S. Downs executive of CNS Pharmaceuticals, Inc., effective 2025-10-24.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:emfpgoegcx6a","event_type":"EXECUTIVE_APPOINTED","effective_at":"2025-10-24","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:person:donald-picker","alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:cb49c5d848561321aa910a1d4ec56809b47f87293f5467949bd6c5b2f5423c81"],"summary":"Donald Picker executive of CNS Pharmaceuticals, Inc., effective 2025-10-24.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:bs4hkaccguuo","event_type":"CEO_CHANGED","effective_at":"2025-10-24","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:person:john-m-climaco","alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:5cba6b40c600c34fde290077803a28f0f74a1e571a97e0fc9c9c73ba1ffcbdc7"],"summary":"John M. Climaco executive of CNS Pharmaceuticals, Inc., effective 2025-10-24.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1cueruu2yj4bm","event_type":"EXECUTIVE_APPOINTED","effective_at":"2025-10-24","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:person:sandra-l-silberman","alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:aa2f24b30f7124b969da88626eb9e0b0526671195f1801914ebd63d98948a5cb"],"summary":"Sandra L. Silberman executive of CNS Pharmaceuticals, Inc., effective 2025-10-24.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1e0rmotejatbz","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:person:amy-mahery","alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259"],"summary":"Amy Mahery seat on CNS Pharmaceuticals, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:osbamdpnlpfz","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:committee:cns-pharmaceuticals-inc:audit-compensation-chair","alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259"],"summary":"Audit; Compensation · Chair committee of CNS Pharmaceuticals, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:18jtpqn1yjklwl","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:person:amy-mahery","alpha:committee:cns-pharmaceuticals-inc:audit-compensation-chair"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259"],"summary":"Amy Mahery member of Audit; Compensation · Chair, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:gfvugv1t0up6f","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:person:bettina-m-cockroft","alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259"],"summary":"Bettina M. Cockroft seat on CNS Pharmaceuticals, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ocwemj1xc1jn3","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:committee:cns-pharmaceuticals-inc:compensation-nominating-and-governance-chair","alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259"],"summary":"Compensation; Nominating and Governance · Chair committee of CNS Pharmaceuticals, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:jyovvxrknfxj","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:person:bettina-m-cockroft","alpha:committee:cns-pharmaceuticals-inc:compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259"],"summary":"Bettina M. Cockroft member of Compensation; Nominating and Governance · Chair, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1x5p6ia9l9vtq","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:person:jeffry-r-keyes","alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259"],"summary":"Jeffry R. Keyes seat on CNS Pharmaceuticals, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bzr4wwc7xk5u","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:committee:cns-pharmaceuticals-inc:audit-chair","alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259"],"summary":"Audit · Chair committee of CNS Pharmaceuticals, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:j1ilsn4yzgi9","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:person:jeffry-r-keyes","alpha:committee:cns-pharmaceuticals-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259"],"summary":"Jeffry R. Keyes member of Audit · Chair, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1h7dczs1e2243e","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:person:jerzy-george-gumulka","alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259"],"summary":"Jerzy (George) Gumulka seat on CNS Pharmaceuticals, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1l48eqz1gl5iq7","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:47:19.235235+00:00","subject_ids":["alpha:person:john-m-climaco","alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551"],"caused_claim_ids":["alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259"],"summary":"John M. Climaco seat on CNS Pharmaceuticals, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:5","subject_id":"alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:amy-mahery","object_label":"Amy Mahery","object_source_name_forms":[],"value":"Amy Mahery: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:amy-mahery","name":"Amy Mahery"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:19.235235+00:00","sources":[{"id":"alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CNS Pharmaceuticals, Inc. DEF 14A 2025-10-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24","retrieved_at":"2026-04-28T22:30:04.627+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-24","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:19.235235+00:00","reviewed_at":"2026-10-17T04:47:19.235235+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:6","subject_id":"alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bettina-m-cockroft","object_label":"Bettina M. Cockroft","object_source_name_forms":[],"value":"Bettina M. Cockroft: Director, Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:bettina-m-cockroft","name":"Bettina M. Cockroft"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:19.235235+00:00","sources":[{"id":"alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CNS Pharmaceuticals, Inc. DEF 14A 2025-10-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24","retrieved_at":"2026-04-28T22:30:04.627+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-24","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:19.235235+00:00","reviewed_at":"2026-10-17T04:47:19.235235+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:7","subject_id":"alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jeffry-r-keyes","object_label":"Jeffry R. Keyes","object_source_name_forms":[],"value":"Jeffry R. Keyes: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jeffry-r-keyes","name":"Jeffry R. Keyes"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:19.235235+00:00","sources":[{"id":"alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CNS Pharmaceuticals, Inc. DEF 14A 2025-10-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24","retrieved_at":"2026-04-28T22:30:04.627+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-24","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:19.235235+00:00","reviewed_at":"2026-10-17T04:47:19.235235+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:8","subject_id":"alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jerzy-george-gumulka","object_label":"Jerzy (George) Gumulka","object_source_name_forms":[],"value":"Jerzy (George) Gumulka: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jerzy-george-gumulka","name":"Jerzy (George) Gumulka"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:19.235235+00:00","sources":[{"id":"alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CNS Pharmaceuticals, Inc. DEF 14A 2025-10-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24","retrieved_at":"2026-04-28T22:30:04.627+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-24","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:19.235235+00:00","reviewed_at":"2026-10-17T04:47:19.235235+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:9","subject_id":"alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-m-climaco","object_label":"John M. Climaco","object_source_name_forms":[],"value":"John M. Climaco: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-m-climaco","name":"John M. Climaco"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:19.235235+00:00","sources":[{"id":"alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CNS Pharmaceuticals, Inc. DEF 14A 2025-10-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24","retrieved_at":"2026-04-28T22:30:04.627+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-24","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:19.235235+00:00","reviewed_at":"2026-10-17T04:47:19.235235+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:10","subject_id":"alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:christopher-s-downs","object_label":"Christopher S. Downs","object_source_name_forms":[],"value":"Christopher S. Downs: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:christopher-s-downs","name":"Christopher S. Downs"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-10-24","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-10-24","valid_to":null,"recorded_at":"2026-10-17T04:47:19.235235+00:00","sources":[{"id":"alpha:projection-evidence:document:1fe3b304eba1ddddf47b03ae23aa7ab289c39ec2888c011ef4c75a6ceb621ff7","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CNSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24T00:00:00+00:00","retrieved_at":"2026-05-16T00:48:42.936925+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-24T00:00:00+00:00","effective_from":"2025-10-24","effective_until":null,"observed_at":"2026-10-17T04:47:19.235235+00:00","reviewed_at":"2026-10-17T04:47:19.235235+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:11","subject_id":"alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:donald-picker","object_label":"Donald Picker","object_source_name_forms":[],"value":"Donald Picker: Chief Science Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:donald-picker","name":"Donald Picker"},"title":"Chief Science Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-10-24","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-10-24","valid_to":null,"recorded_at":"2026-10-17T04:47:19.235235+00:00","sources":[{"id":"alpha:projection-evidence:document:cb49c5d848561321aa910a1d4ec56809b47f87293f5467949bd6c5b2f5423c81","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CNSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24T00:00:00+00:00","retrieved_at":"2026-05-16T00:48:43.881822+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-24T00:00:00+00:00","effective_from":"2025-10-24","effective_until":null,"observed_at":"2026-10-17T04:47:19.235235+00:00","reviewed_at":"2026-10-17T04:47:19.235235+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:12","subject_id":"alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:john-m-climaco","object_label":"John M. Climaco","object_source_name_forms":[],"value":"John M. Climaco: Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:john-m-climaco","name":"John M. Climaco"},"title":"Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-10-24","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-10-24","valid_to":null,"recorded_at":"2026-10-17T04:47:19.235235+00:00","sources":[{"id":"alpha:projection-evidence:document:5cba6b40c600c34fde290077803a28f0f74a1e571a97e0fc9c9c73ba1ffcbdc7","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CNSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24T00:00:00+00:00","retrieved_at":"2026-05-16T00:48:42.427468+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-24T00:00:00+00:00","effective_from":"2025-10-24","effective_until":null,"observed_at":"2026-10-17T04:47:19.235235+00:00","reviewed_at":"2026-10-17T04:47:19.235235+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:14cbf1a0-53bc-4e86-9d90-3af489846551:leadership_role:13","subject_id":"alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:sandra-l-silberman","object_label":"Sandra L. Silberman","object_source_name_forms":[],"value":"Sandra L. Silberman: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:sandra-l-silberman","name":"Sandra L. Silberman"},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-10-24","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-10-24","valid_to":null,"recorded_at":"2026-10-17T04:47:19.235235+00:00","sources":[{"id":"alpha:projection-evidence:document:aa2f24b30f7124b969da88626eb9e0b0526671195f1801914ebd63d98948a5cb","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CNSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24T00:00:00+00:00","retrieved_at":"2026-05-16T00:48:43.39018+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-10-24T00:00:00+00:00","effective_from":"2025-10-24","effective_until":null,"observed_at":"2026-10-17T04:47:19.235235+00:00","reviewed_at":"2026-10-17T04:47:19.235235+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:3a9f2eb407f3e82d62dd1ce85646a3453de4f1d24aab5b53211ae06fc67e1259","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CNS Pharmaceuticals, Inc. DEF 14A 2025-10-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24","retrieved_at":"2026-04-28T22:30:04.627+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:1fe3b304eba1ddddf47b03ae23aa7ab289c39ec2888c011ef4c75a6ceb621ff7","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CNSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24T00:00:00+00:00","retrieved_at":"2026-05-16T00:48:42.936925+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:cb49c5d848561321aa910a1d4ec56809b47f87293f5467949bd6c5b2f5423c81","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CNSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24T00:00:00+00:00","retrieved_at":"2026-05-16T00:48:43.881822+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:5cba6b40c600c34fde290077803a28f0f74a1e571a97e0fc9c9c73ba1ffcbdc7","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CNSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24T00:00:00+00:00","retrieved_at":"2026-05-16T00:48:42.427468+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:aa2f24b30f7124b969da88626eb9e0b0526671195f1801914ebd63d98948a5cb","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CNSP DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825007760/cns_def14a.htm","source_date":"2025-10-24T00:00:00+00:00","retrieved_at":"2026-05-16T00:48:43.39018+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.834,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.896,"cross_source_agreement":0.75,"temporal_completeness":0.5},"diagnostics":{"published_claims":25,"factual_claims":25,"claims_with_linked_evidence":25,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":18,"temporal_claims_with_valid_from":9,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:47:19.235235+00:00","observed_at":"2026-10-17T04:47:19.235235+00:00","reviewed_at":"2026-10-17T04:47:19.235235+00:00","verified_at":"2026-10-17T04:47:19.235235+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":25,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/cns-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/cns-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}